Conditions: Adenocarcinoma of the Pancreas; Adenocarcinoma of the Duodenum; Ampullary Adenocarcinoma
Interventions: Procedure: total pancreatectomy; Biological: intraportal islet autotransplantation
Sponsors: University Hospital, Lille; Ministry of Health, France
Not yet recruiting
Feeds
5250 items (5250 unread) in 74 feeds
Acinar Cell Carcinoma
(12 unread)
Acinic Cell Carcinoma
(18 unread)
Adenoid Cystic Carcinoma
(90 unread)
Adrenal Gland Cancer
(452 unread)
Ampulla Of Vater
(60 unread)
Anal Cancer
(494 unread)
Angiosarcoma
(130 unread)
Appendix Cancer
(85 unread)
Bile Duct Cancer
(664 unread)
Brain and CNS
(597 unread)
Carcinoid
(153 unread)
Endocrine/Neuroendocrine
(652 unread)
Gall Bladder Cancer
(338 unread)
Hemangioendothelioma
(117 unread)
Hepatoblastoma
(151 unread)
Pancreas
(60 unread)
Phyllodes
(26 unread)
PMP and Mucinous Tumors
(39 unread)
Rhabdomyosarcoma
(187 unread)
Sarcoma
(925 unread)
Ampulla Of Vater (60 unread)
Trial - Ampullary Carcinoma
-
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Posted: November 10th, 2021, 3:00pm GMT
PubMed - Ampullary Cancer
-
Rare Orbital Metastasis Originating from Ampullary Adenocarcinoma
Fetched: December 1st, 2021, 5:00am GMT by Yung-En Tsai
Medicina (Kaunas). 2021 Nov 12;57(11):1238. doi: 10.3390/medicina57111238.
ABSTRACT
BACKGROUND: Orbital metastasis from ampullary carcinoma is rare, with no previously reported cases.
CASE PRESENTATION: We report the case of a 60-year-old man who complained of a right-sided headache, blurred vision, progressive proptosis, ptosis, and right eye pain for 3 months. His past medical history included an ampullary adenocarcinoma stage IIIA treated via the Whipple procedure and adjuvant chemoradiotherapy 1 year ago. However, he was lost to follow-up. Computed tomography of the orbit showed a soft tissue lesion in the right orbital fossa measuring 3.3 × 2 × 2 cm. An orbital mass biopsy demonstrated an intestinal-type adenocarcinoma that tested positive for cytokeratins 7 and 20 and CDX2 on immunohistochemical staining. The pathologic diagnosis was metastatic adenocarcinoma from the ampulla of Vater. Despite oncological treatment, the patient's illness progressed. He received palliative treatment and died 1 month later.
CONCLUSIONS: We presented a rare case of orbital metastasis from ampullary adenocarcinoma. This should be considered in the differential diagnosis of patients with a history of ampullary adenocarcinoma who present with symptoms referring to the relevant locations.
PMID:34833456 | PMC:PMC8624159 | DOI:10.3390/medicina57111238
-
Low prevalence of biliary tract cancer with defective mismatch repair genes in a Japanese hospital-based population
Fetched: November 26th, 2021, 5:00am GMT by Yasuhisa Ando
Oncol Lett. 2022 Jan;23(1):4. doi: 10.3892/ol.2021.13122. Epub 2021 Nov 4.
ABSTRACT
Recent studies have reported that immune checkpoint inhibitors are effective against various defective mismatch repair (dMMR)/microsatellite instability-high (MSI-H) cancers. A limited number of reports are available on the frequency of dMMR/MSI-H carcinoma in biliary tract cancer (BTC), describing its clinicopathological characteristics and prognosis. The latter carcinoma is also associated with Lynch syndrome (LS). The present study was performed to investigate the frequency of patients with dMMR/MSI-H in BTC and the clinical characteristics of BTC with dMMR/MSI-H in a single institution in Japan. A total of 116 patients with BTC who underwent curative surgical resection at Kagawa University Hospital between January 2008 and December 2017 were included. The protein expression levels of the mismatch repair (MMR) genes [mutL homolog 1 (MLH1), mismatch repair endonuclease PMS2 (PMS2), MutS homolog (MSH)2 and MSH6] were assessed by immunohistochemistry (IHC) using formalin-fixed paraffin-embedded tissue specimens. Subsequently, MSI testing was performed on patients who exhibited loss of MMR protein expression. Loss of expression of one or more proteins was detected in five cases (4.3%). Loss of MLH1/PMS2 expression was observed in one case of intrahepatic cholangiocarcinoma, whereas loss of PMS2 expression was noted in one case of perihilar cholangiocarcinoma. Loss of MSH2/MSH6 and MSH6 expression was noted in two cases of distal cholangiocarcinoma and loss of PMS2 expression in one case of ampullary carcinoma. Out of the five patients, two demonstrated MSI-H. Microsatellite stability was observed in two cases and for one case, no data were available. Two MSI-H cases were patients with loss of expression of MLH1/PMS2 and MSH2/MSH6. None of the five patients exhibited a past medical history or family history of suspected LS. The frequency of dMMR in BTC was ~5%, which was similar to that reported by similar studies performed in other countries. In the present study, IHC appeared to be more useful than MSI testing for detecting MMR abnormalities with regards to the detection rate. Furthermore, there may only be a limited number of patients with BTCs who are likely to benefit from the therapeutic effects of treatment with immune checkpoint inhibitors.
PMID:34820003 | PMC:PMC8607234 | DOI:10.3892/ol.2021.13122
-
Endoscopic Management and Surgical Considerations for Familial Adenomatous Polyposis
Fetched: November 21st, 2021, 5:00am GMT by Peter P Stanich
Gastrointest Endosc Clin N Am. 2022 Jan;32(1):113-130. doi: 10.1016/j.giec.2021.08.007.
ABSTRACT
Familial adenomatous polyposis (FAP) is the development of many adenomatous colorectal polyps. Colonoscopy is recommended to start at age 10 to 12 years at intervals of 1 to 2 years. Colectomy is clearly indicated for malignancy or significant colorectal symptoms. After colectomy, endoscopic surveillance is still critical. Duodenal and gastric polyposis is also found in almost all patients with FAP. Screening with upper endoscopy and ampullary visualization is recommended, generally determined by age and staging of duodenal polyposis, but guidelines are increasingly factoring in ampullary and gastric manifestations. Surgical management of malignancy or advanced upper tract manifestations is needed.
PMID:34798980 | DOI:10.1016/j.giec.2021.08.007
-
Transitioning to a high volume centre for Whipple pancreaticoduodenectomy in Western Australia: a single centre experience
Fetched: November 19th, 2021, 5:00am GMT by Ho-Cing Victor Yau
ANZ J Surg. 2021 Nov 18. doi: 10.1111/ans.17367. Online ahead of print.
ABSTRACT
BACKGROUND: Pancreaticoduodenectomy (PD) is a curative resection for peri-ampullary tumours associated with high rates of peri-operative mortality and morbidity. The global trend is towards the establishment of high volume centres to reduce this. Australia faces geographical and population distribution challenges. Western Australia has centralized PD to two centres and we present the results of our institution in transitioning to a high volume centre.
METHODS: This was a prospective database of all PDs performed at our institution from 1 January 2005 to 2 April 2020. Mortality outcomes included peri-operative, 30 day and 90 day mortality. Complications, readmission and reinterventions at 90 days were recorded. The annual volume exceeded 20 from 2015. Outcomes prior to this were compared to characterize the transition to a high volume centre.
RESULTS: One hundred and twenty eight PDs were performed in Period 1 (1 January 2005-31 December 2014) and 170 in the high volume Period 2 (1 January 2015-2 April 2020). There was a non-statistically significant reduction in 90 day mortality in Period 2 (4.69% versus 1.18%, p = 0.06). There was a reduction in clinically significant post-operative pancreatic fistulas (31.25% versus 11.76%, p < 0.05), delayed gastric emptying (39.84% versus 22.35%, p < 0.05) and transfusion requirements (56.25% versus 17.65%, p < 0.05). Severe complications (Clavien-Dindo III or greater) were reduced (30.47% versus 18.24%, p < 0.05).
CONCLUSION: Since establishing a high volume service, there was a reduction in post-operative complications and 90 day mortality. This is in line with outcomes from international centres and demonstrates the improvements that can be made.
PMID:34791763 | DOI:10.1111/ans.17367
-
Use of a standardized reporting template: can we improve report quality in pancreatic and peri-ampullary malignancy?
Fetched: November 10th, 2021, 5:01am GMT by Robert Hodnett
ANZ J Surg. 2021 Nov 8. doi: 10.1111/ans.17300. Online ahead of print.
ABSTRACT
BACKGROUND: Accurate pancreatic and periampullary cancer staging with resectability assessment is vital to optimize surgical management and improve patient outcomes. The aim of this study is to assess the usefulness of a standardized reporting template.
METHODS: Retrospective review of all surgically managed patients with pancreatic or periampullary malignancy between January 2018 and June 2019. Pre-operative CT imaging report was anonymised and audited against a modified NCCN reporting template. The same imaging studies were re-reported by two experienced GI radiologists using the same template.
RESULTS: Fifty-nine patients (37 male) with median age of 68 years (36-83) underwent surgery for suspected pancreatic/peri-ampullary malignancy. The median time between pre-operative CT scan and surgery was 56.5 days (14-225). The use of reporting template resulted in significant increase in number of reported key features (p < 0.005), interobserver agreed features (p < 0.005) and overall k-value assessed interobserver agreement (p < 0.005). Template reports correlated closely with key intraoperative findings whilst primary free text reports did not (k-value 0.85-0.96 versus 0.20-0.46, p < 0.05).
CONCLUSION: The use of a reporting template resulted in a more complete and accurate pancreatic/peri-ampullary tumour evaluation, improved inter-observer relatability and correlation with intraoperative findings.
PMID:34747559 | DOI:10.1111/ans.17300
-
Predictive value of metabolic activity detected by pre-operative 18F FDG PET/CT in ampullary adenocarcinoma
Fetched: November 5th, 2021, 5:00am GMT by Young Mok Park
Medicine (Baltimore). 2021 Oct 22;100(42):e27561. doi: 10.1097/MD.0000000000027561.
ABSTRACT
In ampullary adenocarcinoma cases, the clinical effects of 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) have not yet been well-studied, unlike other prognostic factors that have been reported till date. This study aimed to investigate the clinical impact of maximum standardized uptake value (SUVmax) in predicting the prognosis of ampullary adenocarcinoma.Thirty-eight patients who underwent pre-operative 18F-FDG PET/CT and curative-intent resection of ampullary adenocarcinoma at Pusan National University Hospital (Pusan, South Korea) between 2008 and 2017 were retrospectively analyzed in this study. We evaluated the clinicopathologic outcomes according to the SUVmax using univariate and multivariate Cox proportional hazard regression analyses and receiver operating characteristic analysis to arrive at a cutoff value.Lymph node metastasis was detected in 9 patients, and 15 patients experienced a recurrence during the follow-up period. Among 38 patients, 33 showed an increased FDG uptake by the main tumor. SUVmax of 4.55 was selected as a significant independent predictive factor for patient survival along with poor tumor differentiation and high neutrophil-to-lymphocyte ratio in multivariate analysis (P = .016, hazard ratio = 5.040). Patients with SUVmax under 4.55 exhibited significantly longer overall survival than the rest (<4.55 vs ≥4.55), and the 5-year overall survival was 82.8% versus 57.4% (P = .049).SUVmax of 4.55 on 18F-FDG PET/CT could be a predictive factor for tumor biology and long-term survival in patients with ampullary adenocarcinoma. Nevertheless, considering the cost aspect and its limited prognostic effect, this study seems to require more patient and multicenter studies.
PMID:34678895 | PMC:PMC8542133 | DOI:10.1097/MD.0000000000027561
-
A duodenal ampullary tumor with malignant transformation of papillary polyps: a case report and literature review
Fetched: November 3rd, 2021, 5:00am GMT by Wenhui Mo
J Int Med Res. 2021 Oct;49(10):3000605211053230. doi: 10.1177/03000605211053230.
ABSTRACT
Periampullary carcinoma refers to a malignant tumor within 2 cm of the duodenal ampulla. Primary ampullary carcinoma is very rare, accounting for only 0.2% of malignant gastrointestinal tumors. The small intestine accounts for 75% of the length of the gastrointestinal tract, and primary tumors in the small intestine account for only 2% of all gastrointestinal tumors. Here, we report the case of a duodenal ampullary tumor with malignant transformation of parapapillary polyps. The patient had both a primary ampullary tumor and high-grade intraepithelial neoplasia of juxtapapillary adenomatous duodenal polyps.
PMID:34719989 | PMC:PMC8562643 | DOI:10.1177/03000605211053230
-
Endoscopic radiofrequency ablation for malignant biliary obstruction
Fetched: November 2nd, 2021, 5:00am GMT by Jana Jarosova
World J Gastrointest Oncol. 2021 Oct 15;13(10):1383-1396. doi: 10.4251/wjgo.v13.i10.1383.
ABSTRACT
Cholangiocarcinoma and pancreatic cancer are the most common causes of malignant biliary obstruction. The majority of patients are diagnosed at a late stage when surgical resection is rarely possible. In these cases, palliative chemotherapy and radiotherapy provide only limited benefit and are associated with poor survival. Radiofrequency ablation (RFA) is a procedure for locoregional control of tumours, whereby a high-frequency alternating current turned into thermal energy causes coagulative necrosis of the tissue surrounding the catheter. The subsequent release of debris and tumour antigens by necrotic cells can stimulate local and systemic immunity. The development of endoluminal RFA catheters has led to the emergence of endoscopically delivered RFA, a treatment mainly used for malignant biliary strictures to prolong survival and/or stent patency. Other indications include recanalisation of occluded biliary stents and treatment of intraductal ampullary adenoma or benign biliary strictures. This article presents a comprehensive review of endobiliary RFA, mainly focusing on its use in patients with malignant biliary obstruction. The available data suggest that biliary RFA may be a promising modality, having positive impacts on survival and stent patency and boasting a reasonable safety profile. However, further studies with better characterised and stratified patient populations are needed before the method becomes accepted within routine clinical practice.
PMID:34721772 | PMC:PMC8529920 | DOI:10.4251/wjgo.v13.i10.1383
Google - Ampullary Cancer
-
World Pancreatic Cancer Day: 9 warning signs to watch out for - WFTV Orlando
Posted: November 18th, 2021, 7:31pm GMT
-
ROBERTTA LEITZA Obituary (1948 - 2021) - LAKE VILLA, IL - Daily Herald - Legacy.com
Posted: November 18th, 2021, 2:39am GMT
-
Pancreatic cancer symptoms: Two 'early warning signs' of the 'silent disease' - Times Now
Posted: November 16th, 2021, 12:37pm GMT
-
Leading doctor nicknamed patient ‘Little Miss Trouble’ - Evening Standard
Posted: November 15th, 2021, 1:36pm GMT
Leading doctor nicknamed patient ‘Little Miss Trouble’ Evening Standard -
Leading doctor nicknamed patient ‘Little Miss Trouble’ - Evening Standard
Posted: November 15th, 2021, 1:36pm GMT
Leading doctor nicknamed patient ‘Little Miss Trouble’ Evening Standard -
Politicians mourn death of ex-envoy - Taipei Times
Posted: November 12th, 2021, 2:00pm GMT
Politicians mourn death of ex-envoy Taipei Times -
Political leaders mourn Taiwan's former top envoy to Thailand - Focus Taiwan News Channel
Posted: November 12th, 2021, 6:22am GMT
Political leaders mourn Taiwan's former top envoy to Thailand Focus Taiwan News Channel -
Illinois Golfer Nabs Hole-in-One Upon His Return to the Golf Course Following Treatment for Rare Cancer: ‘It Brought a Tear to My Eye’ - SurvivorNet
Posted: November 12th, 2021, 6:00am GMT
-
From a rare cancer to a rare hole-in-one: A golfer's triumphant return - Chicago Daily Herald
Posted: November 11th, 2021, 5:31pm GMT
From a rare cancer to a rare hole-in-one: A golfer's triumphant return Chicago Daily Herald -
Marinette City Council debates properties in 20-year comprehensive plan - Bay Cities Radio
Posted: November 5th, 2021, 4:19am GMT
-
Gene signature IDs drivers of treatment resistance in metastatic breast cancer - Baylor College of Medicine News
Posted: October 28th, 2021, 5:00am GMT
Gene signature IDs drivers of treatment resistance in metastatic breast cancer Baylor College of Medicine News -
A heart that beats (almost) like our own: Biologists unravel how fruit fly 'head-heart' functions - Science Daily
Posted: October 27th, 2021, 5:00am GMT
-
Owodunni named to BCM Board of Trustees | BCM - Baylor College of Medicine News
Posted: October 27th, 2021, 5:00am GMT
Owodunni named to BCM Board of Trustees | BCM Baylor College of Medicine News -
AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind - FiercePharma
Posted: October 25th, 2021, 2:25pm GMT
- AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind FiercePharma
- AstraZeneca Announces Potential Breakthrough in Advanced Biliary Tract Cancer BioSpace
- Durvalumab Plus Chemo Significantly Improves OS in Frontline Advanced Biliary Tract Cancer OncLive
- Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis | Antibodies | News Channels PipelineReview.com
- Imfinzi™ improves overall survival in biliary tract cancer (BTC) patients European Pharmaceutical Review
- View Full Coverage on Google News
-
AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind - FiercePharma
Posted: October 25th, 2021, 2:25pm GMT
-
AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind - FiercePharma
Posted: October 25th, 2021, 5:00am GMT
- AstraZeneca's Imfinzi strikes immunotherapy's first win in bile duct cancer, with Merck's Keytruda behind FiercePharma
- AstraZeneca Announces Potential Breakthrough in Advanced Biliary Tract Cancer BioSpace
- IMFINZI Plus Chemotherapy Significantly Improved Overall Survival in 1st-Line Advanced Biliary Tract Cancer in TOPAZ-1 Phase III Trial at Interim Analysis Business Wire
- Durvalumab Plus Chemo Significantly Improves OS in Frontline Advanced Biliary Tract Cancer OncLive
- Imfinzi™ improves overall survival in biliary tract cancer (BTC) patients European Pharmaceutical Review
- View Full Coverage on Google News
-
Baylor researchers part of Precision Aging Network - Baylor College of Medicine News
Posted: October 25th, 2021, 5:00am GMT
Baylor researchers part of Precision Aging Network Baylor College of Medicine News -
Durvalumab Plus Chemo Significantly Improves OS in Frontline Advanced Biliary Tract Cancer - OncLive
Posted: October 25th, 2021, 5:00am GMT
-
AstraZeneca : Imfinzi plus chemotherapy significantly improved overall survival in 1st-line advanced biliary tract cancer in TOPAZ-1 Phase III trial at interim analysis - Marketscreener.com
Posted: October 25th, 2021, 4:04am GMT
-
COVID safety tricks to make this Halloween a treat - Baylor College of Medicine News
Posted: October 20th, 2021, 5:00am GMT
COVID safety tricks to make this Halloween a treat Baylor College of Medicine News -
Baylor, Hess release STEM guide for 2021 Cargo Plane and Jet - Baylor College of Medicine News
Posted: October 20th, 2021, 5:00am GMT
Baylor, Hess release STEM guide for 2021 Cargo Plane and Jet Baylor College of Medicine News -
NuCana Receives Fast Track Designation from the US Food - GlobeNewswire
Posted: September 29th, 2021, 5:00am GMT
NuCana Receives Fast Track Designation from the US Food GlobeNewswire -
TRISH demonstrates performance of portable handheld ultrasound in space - Baylor College of Medicine News
Posted: September 29th, 2021, 5:00am GMT
TRISH demonstrates performance of portable handheld ultrasound in space Baylor College of Medicine News -
The International Vaccine Institute, TCH and BCM partner for vaccine research | BCM - Baylor College of Medicine News
Posted: September 28th, 2021, 5:00am GMT
The International Vaccine Institute, TCH and BCM partner for vaccine research | BCM Baylor College of Medicine News -
Novel technology makes studying gene function easier, faster - Baylor College of Medicine News
Posted: September 14th, 2021, 5:00am GMT
Novel technology makes studying gene function easier, faster Baylor College of Medicine News -
NIH award supports diverse researchers in All of US Research Program - Baylor College of Medicine News
Posted: September 9th, 2021, 5:00am GMT
NIH award supports diverse researchers in All of US Research Program Baylor College of Medicine News -
Chevron, Texaco team up with Baylor to Raise Funds for Alzheimer's Research - Baylor College of Medicine News
Posted: September 1st, 2021, 5:00am GMT
Chevron, Texaco team up with Baylor to Raise Funds for Alzheimer's Research Baylor College of Medicine News -
Space Health Institute grants support studies on reducing metabolism - Baylor College of Medicine News
Posted: August 31st, 2021, 5:00am GMT
Space Health Institute grants support studies on reducing metabolism Baylor College of Medicine News -
New center funds research to advance at-home healthcare technology - Baylor College of Medicine News
Posted: August 26th, 2021, 5:00am GMT
New center funds research to advance at-home healthcare technology Baylor College of Medicine News -
Genetic cause of endometriosis IDed, potential drug target revealed - Baylor College of Medicine News
Posted: August 25th, 2021, 5:00am GMT
Genetic cause of endometriosis IDed, potential drug target revealed Baylor College of Medicine News -
Getting kids on a regular sleep schedule after virtual year - Baylor College of Medicine News
Posted: August 12th, 2021, 5:00am GMT
Getting kids on a regular sleep schedule after virtual year Baylor College of Medicine News -
Expert provides insight on sports and mental health - Baylor College of Medicine News
Posted: July 27th, 2021, 5:00am GMT
Expert provides insight on sports and mental health Baylor College of Medicine News -
Eating for hunger or pleasure involves regulating different brain circuits - Baylor College of Medicine News
Posted: July 26th, 2021, 5:00am GMT
Eating for hunger or pleasure involves regulating different brain circuits Baylor College of Medicine News -
Tips to protect your skin this summer - Baylor College of Medicine News
Posted: July 22nd, 2021, 5:00am GMT
Tips to protect your skin this summer Baylor College of Medicine News -
Calcium scores can help statin therapy decisions - Baylor College of Medicine News
Posted: July 14th, 2021, 5:00am GMT
Calcium scores can help statin therapy decisions Baylor College of Medicine News -
ASHG Honors Dr. C. Thomas Caskey with the 2021 William Allan Award - Baylor College of Medicine News
Posted: July 12th, 2021, 5:00am GMT
ASHG Honors Dr. C. Thomas Caskey with the 2021 William Allan Award Baylor College of Medicine News -
Natera's MRD test shows clinical utility in colorectal cancer - Medical Device Network
Posted: July 5th, 2021, 5:00am GMT
Natera's MRD test shows clinical utility in colorectal cancer Medical Device Network -
Restoring molecular clock suppresses neuroblastoma tumor growth - Baylor College of Medicine News
Posted: June 28th, 2021, 5:00am GMT
Restoring molecular clock suppresses neuroblastoma tumor growth Baylor College of Medicine News -
Know the signs: Heat exhaustion can quickly turn to heat stroke - Baylor College of Medicine News
Posted: June 28th, 2021, 5:00am GMT
Know the signs: Heat exhaustion can quickly turn to heat stroke Baylor College of Medicine News -
Biologists construct a 'periodic table' for cell nuclei - Baylor College of Medicine News
Posted: May 27th, 2021, 5:00am GMT
Biologists construct a 'periodic table' for cell nuclei Baylor College of Medicine News -
Joel Chadabe, Explorer of Electronic Music’s Frontier, Dies at 82 - The New York Times
Posted: May 25th, 2021, 5:00am GMT
Joel Chadabe, Explorer of Electronic Music’s Frontier, Dies at 82 The New York Times -
NIH funds Texas health institutes for HIV research - Baylor College of Medicine News
Posted: May 13th, 2021, 5:00am GMT
NIH funds Texas health institutes for HIV research Baylor College of Medicine News -
How to stay safe when attending sports events - Baylor College of Medicine News
Posted: May 3rd, 2021, 5:00am GMT
How to stay safe when attending sports events Baylor College of Medicine News -
Biological E. Limited to begin Phase III clinical trials with Baylor and Texas Children's vaccine - Baylor College of Medicine News
Posted: April 26th, 2021, 5:00am GMT
Biological E. Limited to begin Phase III clinical trials with Baylor and Texas Children's vaccine Baylor College of Medicine News -
Mouse model closely reproduces human fatty liver disease - Baylor College of Medicine News
Posted: April 12th, 2021, 5:00am GMT
Mouse model closely reproduces human fatty liver disease Baylor College of Medicine News -
Baylor College of Medicine names new endowed chairs - Baylor College of Medicine News
Posted: February 24th, 2021, 6:00am GMT
Baylor College of Medicine names new endowed chairs Baylor College of Medicine News -
Fresno veteran inspired a PBR ‘Buck Cancer’ movement. A bull was renamed in her memory - Fresno Bee
Posted: January 21st, 2021, 6:00am GMT
-
Yash Krishnan - Alex's Lemonade Stand Foundation
Posted: April 6th, 2020, 1:11pm GMT
Yash Krishnan Alex's Lemonade Stand Foundation -
Potential therapeutic value of primary tumor resection in ampullary ca | CMAR - Dove Medical Press
Posted: December 24th, 2018, 6:00am GMT
-
Cancer Drug Proves to Be Effective Against Multiple Tumors - The New York Times
Posted: June 8th, 2017, 5:00am GMT
Cancer Drug Proves to Be Effective Against Multiple Tumors The New York Times -
Chemotherapy can help after periampullary cancer resection - Oncology Nurse Advisor
Posted: August 2nd, 2012, 5:00am GMT
Chemotherapy can help after periampullary cancer resection Oncology Nurse Advisor